Targeted Delivery of Epidermal Growth Factor to the Human Placenta to Treat Fetal Growth Restriction

Placental dysfunction is the underlying cause of pregnancy complications such as fetal growth restriction (FGR) and pre-eclampsia. No therapies are available to treat a poorly functioning placenta, primarily due to the risks of adverse side effects in both the mother and the fetus resulting from sys...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Lewis J. Renshall, Frances Beards, Angelos Evangelinos, Susan L. Greenwood, Paul Brownbill, Adam Stevens, Colin P. Sibley, John D. Aplin, Edward D. Johnstone, Tambet Teesalu, Lynda K. Harris
Format:	article
Langue:	EN
Publié:	MDPI AG 2021
Sujets:	placenta pregnancy fetal growth restriction liposomes epidermal growth factor Pharmacy and materia medica RS1-441
Accès en ligne:	https://doaj.org/article/31d09fe8761e42b3bf935d5bee54fcfc
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Soyez le premier à ajouter un commentaire!

Targeted Delivery of Epidermal Growth Factor to the Human Placenta to Treat Fetal Growth Restriction

Documents similaires